Leonide Saad

Leonide Saad is the President & CEO of Alkeus Pharmaceuticals, Inc., a fast-growing biopharmaceutical company focused on developing therapies for serious eye diseases. Prior to this, Leonide held roles as Vice President and Partner at 21 West Partners, and as a Senior Associate at Proteus Venture Partners. Leonide holds a PhD in Tissue Engineering from Massachusetts Institute of Technology, along with other advanced degrees in Mechanical Engineering and Fundamental Sciences & Organic Chemistry.